Between 20 and 40% of people with lung cancer develop and die from cancer of the brain. Merck "should" be VERY concerned that their
"lucrative lung cancer space" is FAR from being THE answer!!!! Surely they NEED to add a conjunctive antibody to claim having a much more effective treatment and even more dominance of that space??
Between 20 and 40% of people with lung cancer develop and die...
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.51M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.9¢ | $18.68K | 2.075M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 2642383 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 856022 | 2 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
0.9¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.9¢ | 0.9¢ | 0.9¢ | 97616 | ||
| Last updated 11.58am 26/04/2024 ? | |||||
| PAB (ASX) Chart |